These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 9486504

  • 21. Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Mahmut N, Katayama Y, Takenaka K, Teshima T, Ohno Y, Imajyo K, Hara M, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Harada M.
    Int J Hematol; 1999 Jan; 69(1):36-42. PubMed ID: 10641441
    [Abstract] [Full Text] [Related]

  • 22. Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.
    Janssen JJ, van Rijn RS, van der Holt B, Schuurhuis GJ, Vellenga E, Verhoef GE, Ossenkoppele GJ, van den Berg E, Hagemeijer A, Släter R, Nieuwint AW, Cornelissen JJ.
    Bone Marrow Transplant; 2000 Jun; 25(11):1147-55. PubMed ID: 10849527
    [Abstract] [Full Text] [Related]

  • 23. t(3;21) following peripheral blood stem cell transplantation in chronic phase chronic myeloid leukaemia.
    Jacob A, Griffiths M, Larkins S, Holmes J.
    Bone Marrow Transplant; 1997 Jun; 19(12):1255-8. PubMed ID: 9208122
    [Abstract] [Full Text] [Related]

  • 24. [Allogeneic peripheral stem cell transplantation (PBSCT) for hematological malignancies].
    Wu B, Sun J, Meng F.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):420-3. PubMed ID: 11721423
    [Abstract] [Full Text] [Related]

  • 25. Autologous transplant for CML revisited.
    Daley GQ, Goldman JM.
    Exp Hematol; 1993 Jun; 21(6):734-7. PubMed ID: 8500574
    [Abstract] [Full Text] [Related]

  • 26. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myeloid leukemia (CML).
    Podestà M, Piaggio G, Frassoni F, Sessarego M, Benvenuto F, Figari O, Pitto A, Vassallo F, Soracco M, Pollicardo N.
    Bone Marrow Transplant; 1995 Oct; 16(4):549-55. PubMed ID: 8528171
    [Abstract] [Full Text] [Related]

  • 27. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
    Kroschinsky F, Friedrich K, Hanel M, Mohr B, Langer T, Meinhardt M, Thiede C, Bornhauser M, Baretton G, Ehninger G.
    Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
    [Abstract] [Full Text] [Related]

  • 28. Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate.
    Perseghin P, Gambacorti-Passerini C, Tornaghi L, Dassi M, Pioltelli P, Parma M, Colnaghi F, Giudici G, Elli E, Fumagalli M, Ponchio L, Biondi A, Pogliani EM.
    Transfusion; 2005 Jul; 45(7):1214-20. PubMed ID: 15987369
    [Abstract] [Full Text] [Related]

  • 29. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
    Rondelli D, Re F, Bandini G, Raspadori D, Arpinati M, Senese B, Stanzani M, Bonifazi F, Falcioni S, Chirumbolo G, Tura S.
    Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S, Onida F, Beran M, Champlin RE, de Lima M.
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [Abstract] [Full Text] [Related]

  • 31. Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis.
    Podestà M, Piaggio G, Sessarego M, Pitto A, Figari O, Soracco M, Carella AM, Dejana A, Rosti V, Fugazza G, Ravera G, Lerma E, Cazzola M, Bacigalupo A, Frassoni F.
    Exp Hematol; 2000 Feb; 28(2):210-5. PubMed ID: 10706077
    [Abstract] [Full Text] [Related]

  • 32. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 33. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
    Schultheis B, Pasternak G, Hehlmann R.
    Folia Biol (Praha); 2000 Apr; 46(6):256-63. PubMed ID: 11140859
    [Abstract] [Full Text] [Related]

  • 34. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
    Siebolts U, Thiele J, Zander T, Ditschkowski M, Beelen DW, Kröger N, Fehse B, Wickenhauser C.
    Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
    [Abstract] [Full Text] [Related]

  • 35. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ, Li JL, Zhu HH, Ruan GR, Li LD, Zhang Y, Xu LP, Liu DH, Liu YR, Huang XJ, Chen SS, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients.
    Carrasco M, Sureda A, Martínez C, Carmona M, Altés A, Martín-Henao GA, Aventín A, Sierra J.
    Ann Hematol; 2002 Dec; 81(12):710-6. PubMed ID: 12483367
    [Abstract] [Full Text] [Related]

  • 38. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
    Pratt G, Johnson RJ, Rawstron AC, Barnard DL, Morgan GJ, Smith GM.
    Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037
    [Abstract] [Full Text] [Related]

  • 39. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon.
    McBride NC, Cavenagh JD, Newland AC, Lillington DM, Murrell C, Kelsey SM.
    Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726
    [Abstract] [Full Text] [Related]

  • 40. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M, Nagler A, Lishner M, Amiel A, Yarkoni S, Rudi A, Gellerman G, Kashman Y, Fabian I.
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.